Class of Stock [Axis] Total current assets Total Assets Total current liabilities Related and Nonrelated Parties [Axis] Total Liabilities Total Stockholders’ Deficit Balance Balance Total Liabilities and Stockholders’ Deficit Gross profit Total operating costs and expenses Operating loss Total other expense, net Net loss Net loss Total comprehensive loss Balance (in Shares) Balance (in Shares) Equity Components [Axis] Net cash used in operating activities Net cash provided by financing activities Net decrease in cash Cash, beginning of period Cash, end of period Nature of the Business [Abstract] Summary of Significant Accounting Policies [Abstract] Long-Lived Tangible Asset [Axis] Recapitalization [Abstract] Net liabilities assumed in exchange for common stock Non-cash net liabilities assumed in exchange for common stock Fair Value Measurements [Abstract] Total Measurement Frequency [Axis] Fair Value Hierarchy and NAV [Axis] Schedule of Liabilities Measured at Fair Value [Abstract] Balance beginning Balance ending Measurement Input Type [Axis] Balance at beginning Balance at ending Notes payable - at fair value Statistical Measurement [Axis] Research and Development Revenue [Abstract] Financial Instrument [Axis] Liability Class [Axis] Balance at beginning Balance at ending Deferred revenue Accrued Expenses [Abstract] Schedule of Accrued Expenses [Abstract] Total accrued expenses Accrued expenses Notes Payable [Abstract] Debt Instrument [Axis] Commitments and Contingencies [Abstract] Leases [Abstract] Schedule of Operating Lease [Abstract] Operating leases Schedule of Lease Cost Included in General and Administrative Expense [Abstract] Operating lease expense Total rent expense Schedule of Non-Cancelable Operating Lease [Abstract] Total Stockholders’ Equity [Abstract] Stockholders’ Deficit Stock-Based Compensation [Abstract] Schedule of RSU Activities [Abstract] Number of Shares, Nonvested beginning balance Number of Shares, Nonvested ending balance Weighted Average Grant Date Fair Value per Share, Nonvested beginning balance Weighted Average Grant Date Fair Value per Share, Nonvested ending balance Schedule of Assumptions for Stock Options Granted [Abstract] Schedule of Stock Options Activity [Abstract] Stock Options, Outstanding Ending Balance Stock Options, Outstanding Ending Balance Weighted Average Exercise Price, Outstanding Ending Balance Weighted Average Exercise Price, Outstanding Ending Balance Exercise price (in Dollars per share) Aggregate Intrinsic Value, Outstanding Ending Balance Aggregate Intrinsic Value, Outstanding Ending Balance Income Taxes [Abstract] Net Loss Per Common Share [Abstract] Net loss per share of common stock Antidilutive Securities [Axis] Related Party Transactions [Abstract] Subsequent Events [Abstract] Assets Current assets: Cash Accounts receivable, net Inventory Deferred offering costs Prepaid expenses Other current assets Non-current assets: Property and equipment, net Right-of-use assets Commitments and contingencies (Note 8) Liabilities and Stockholders’ Deficit Current liabilities: Accounts payable Lease liabilities, short-term Notes payable Warrant liabilities Notes payable - related party Lease liabilities, long-term Preferred stock ($0.0001 par value); 1,000,000 shares authorized; no shares issued and outstanding as of September 30, 2024 and December 31, 2023 Preferred stock, par value (in Dollars per share) Preferred stock, shares authorized Preferred stock, shares authorized (in Shares) Preferred stock, shares issued Preferred stock, shares outstanding Common stock ($0.0001 par value); 80,000,000 shares authorized; 18,513,073 and 16,294,935 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively Common stock, par value (in Dollars per share) Common stock par value (in Dollars per share) Common stock, shares authorized Common stock, shares authorized (in Shares) Common stock, shares issued Common stock shares issued (in Shares) Common stock, shares outstanding Additional paid-in capital Accumulated other comprehensive income Accumulated deficit Research and development revenue Revenue Operating costs and expenses: General and administrative Other income (expense): Net interest (expense) income Foreign exchange transaction loss, net Loss before income taxes Basic net loss per share of common stock (in Dollars per share) Diluted net loss per share of common stock (in Dollars per share) Weighted average common shares outstanding Basic Weighted average common shares outstanding (in Shares) Diluted Weighted average common shares outstanding (in Shares) (in Shares) Other comprehensive income (loss): Foreign currency translation adjustments Stock-based compensation Sale of common stock Aggregate gross proceeds Sale of common stock (in Dollars) Sale of common stock (in Shares) Cumulative translation adjustment Issuance of common stock under the SEPA Issuance of common stock under the SEPA (in Shares) Issuance of shares for transaction costs (in Shares) Vesting of restricted stock units Vesting of restricted stock units (in Shares) Stock-based compensation (in Shares) Stock option exercises Stock option exercises (in Shares) Issuance of common stock upon Business Combination Issuance of common stock upon Business Combination (in Shares) Issuance of common stock to settle accounts payable Issuance of common stock to settle accounts payable (in Shares) Issuance of shares for transaction costs Stock issuance costs Issuance of shares for transaction costs (in Shares) Commitment to issue shares for transaction costs Private placement equity issuance Private placement equity issuance (in Shares) Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Depreciation expense Stock-based compensation Issuance of shares for transaction costs Commitment to issue shares for transaction costs Change in fair value of warrant liabilities Change in fair value of warrant liability Costs from issuance of common stock Issuance of shares for borrowing related costs Changes in operating assets and liabilities: Accounts payable Accrued expenses Deferred revenue Lease liabilities Cash flows from financing activities: Proceeds from issuance of common stock Proceeds from notes payable Proceeds from notes payable - related party Stock option exercises Effect of exchange rate changes on cash Supplemental cash flow information: Cash paid for interest Cash paid for taxes Noncash operating and financing activities disclosure: Recognition of Right-of-use assets and related lease liabilities upon lease amendment Right-of-use assets exchanged for operating lease liabilities Issuance of common stock for net liabilities upon Business Combination Prepaid asset acquired, net of cancellation, for debt and accounts payable Issuance of common stock to settle accounts and notes payable Cost of revenue Borrowing related costs Change in fair value of notes payable Other income (expenses), including transactions costs Income tax benefit (provision) Income tax provision Amortization of right-of-use assets Change in fair value of notes payable Accounts receivable Inventory Unbilled revenue Prepaid expenses Other assets Cash received in Business Combination Payments for notes payable Common Stock, par value $0.0001 per share Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 Related Party Common Stock Common Stock [Member] Additional Paid-in Capital